Dietary vitamin E, brain redox status and expression of Alzheimer's disease-relevant genes in rats

British Journal of Nutrition

Volumn 102, Issue 3, 2009, Pages 398-406

  Gaedicke, Sonja ^a   Zhang, Xiangnan ^b   Huebbe, Patricia ^a   Boesch Saadatmandi, Christine ^a   Lou, Yijia ^b   Wiswedel, Ingrid ^c   Gardemann, Andreas ^c   Frank, Jan ^a   Rimbach, Gerald ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b ZHEJIANG UNIVERSITY   (China)

^c OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Alzheimer's disease; Brain; Gene expression; Rat; Redox status; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; GLUTATHIONE; GLUTATHIONE PEROXIDASE; ISOPROSTANE; PROSTAGLANDIN F2; SELENIUM; SUPEROXIDE DISMUTASE; ANTIOXIDANT; BIOLOGICAL MARKER; GAMMA TOCOPHEROL; ISOPROSTANE DERIVATIVE; TOCOPHEROL; VITAMIN;

ALPHA TOCOPHEROL DEFICIENCY; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN LEVEL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; DISEASE COURSE; ENZYME ACTIVITY; FOOD COMPOSITION; GENE CONTROL; GENE EXPRESSION; NONHUMAN; OXIDATION REDUCTION REACTION; RAT; VITAMIN BLOOD LEVEL; ANIMAL; BLOOD; COMPARATIVE STUDY; DIET; DOSE RESPONSE; FISCHER 344 RAT; GENETICS; MALE; METABOLISM; METHODOLOGY; OXIDATIVE STRESS; RANDOMIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

RATTUS;

ALPHA-TOCOPHEROL; ALZHEIMER DISEASE; ANIMALS; ANTIOXIDANTS; BIOLOGICAL MARKERS; BRAIN CHEMISTRY; DIET; DOSE-RESPONSE RELATIONSHIP, DRUG; F2-ISOPROSTANES; GAMMA-TOCOPHEROL; GENE EXPRESSION; GLUTATHIONE; MALE; OXIDATION-REDUCTION; OXIDATIVE STRESS; RANDOM ALLOCATION; RATS; RATS, INBRED F344; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TOCOPHEROLS; VITAMINS;

EID: 70149117495     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S000711450819122X     Document Type: Article

References (57)

1. Christen Y (2000) Oxidative stress and Alzheimer disease. Am J Clin Nutr 71, 621S-629S.
2. Engelhart MJ, Geerlings MI, Ruitenberg A, et al. (2002) Dietary intake of antioxidants and risk of Alzheimer disease. J Am Med Assoc 287, 3223-3229.
3. Morris MC, Beckett LA, Scherr PA, et al. (1998) Vitamin E and vitamin C supplement use and risk of incident Alzheimer disease. Alzheimer Dis Assoc Disord 12, 121-126.
4. Morris MC, Evans DA, Tangney CC, et al. (2005) Relation of the tocopherol forms to incident Alzheimer disease and to cognitive change. Am J Clin Nutr 81, 508-514.
5. Food and Nutrition Board of the Institute of Medicine (2000) Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. Washington, DC: National Academy Press.
6. Fillenbaum GG, Kuchibhatla MN, Hanlon JT, et al. (2005) Dementia and Alzheimer's disease in community-dwelling elders taking vitamin C and/or vitamin E. Ann Pharmacother 39, 2009-2014.
7. Petersen RC, Thomas RG, Grundman M, et al. (2005) Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med 352, 2379-2388.
8. Sano M, Ernesto C, Thomas RG, et al. (1997) A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. N Engl J Med 336, 1216-1222.
9. Onofrj M, Thomas A, Luciano AL, et al. (2002) Donepezil versus vitamin E in Alzheimer's disease: Part 2: mild versus moderate-severe Alzheimer's disease. Clin Neuropharmacol 25, 207-215.
10. Lampi AM, Hopia A, Ekholm P, et al. (1992) Method for the preparation of triacylglycerol fractions from rapeseed and other oils for autoxidation studies. Food Sci Technol 25, 386-388.
11. National Research Council Nutrient Requirements of the Laboratory Rat (1995) Nutrient Requirements of Laboratory Animals, pp. 11-79. Washington, DC: National Academic Press.
12. Wiswedel I, Hirsch D, Kropf S, et al. (2004) Flavanol-rich cocoa drink lowers plasma F(2)-isoprostane concentrations in humans. Free Radic Biol Med 37, 411-421.
13. Morrow DM, Zackert WE, Van der Ende DS, et al. (2002) Quantification of isoprostanes as indicators of oxidant stress in vivo. In Handbook of Antioxidants, 2nd ed., pp. 57-74 [E Cadenas and L Packer, editors]. New york: Marcel Dekker.
14. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72, 248-254.
15. Marklund S & Marklund G (1974) Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 47, 469-474.
16. Lawrence RA & Burk RF (1976) Glutathione peroxidase activity in selenium-deficient rat liver. Biochem Biophys Res Commun 71, 952-958.
17. Tietze F (1969) Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem 27, 502-522.
18. Dringen R & Hamprecht B (1996) Glutathione content as an indicator for the presence of metabolic pathways of amino acids in astroglial cultures. J Neurochem 67, 1375-1382.
19. Grundman M, Grundman M & Delaney P (2002) Antioxidant strategies for Alzheimer's disease. Proc Nutr Soc 61, 191-202.
20. Grusak MA & DellaPenna D (1999) Improving the nutrient composition of plants to enhance human nutrition and health. Annu Rev Plant Physiol Plant Mol Biol 50, 133-161.
21. Barella L, Muller PY, Schlachter M, et al. (2004) Identification of hepatic molecular mechanisms of action of alpha-tocopherol using global gene expression profile analysis in rats. Biochim Biophys Acta Mol Basis Dis 1689, 66-74.
22. Vatassery GT, Brin MF, Fahn S, et al. (1988) Effect of high doses of dietary vitamin E on the concentrations of vitamin E in several brain regions, plasma, liver, and adipose tissue of rats. J Neurochem 51, 621-623.
23. Martin A, Janigian D, Shukitt-Hale B, et al. (1999) Effect of vitamin E intake on levels of vitamins E and C in the central nervous system and peripheral tissues: implications for health recommendations. Brain Res 845, 50-59.
24. Pappert EJ, Tangney CC, Goetz CG, et al. (1996) Alpha-tocopherol in the ventricular cerebrospinal fluid of Parkinson's disease patients: dose-response study and correlations with plasma levels. Neurology 47, 1037-1042.
25. Clement M, Dinh L & Bourre JM (1995) Uptake of dietary RRR-alpha- and RRR-gamma-tocopherol by nervous tissues, liver and muscle in vitamin-E-deficient rats. Biochim Biophys Acta 1256, 175-180.
26. Handelman GJ, Machlin LJ, Fitch K, et al. (1985) Oral alphatocopherol supplements decrease plasma gamma-tocopherol levels in humans. J Nutr 115, 807-813.
27. Melchert H-U & Pabel E (1998) The tocoperol pattern in human serum is markedly influenced by intake of vitamin E drugs - results of the German national health surveys. J Am Oil Chem Soc 75, 213-216.
28. Huang HY & Appel LJ (2003) Supplementation of diets with alpha-tocopherol reduces serum concentrations of gamma- and delta-tocopherol in humans. J Nutr 133, 3137-3140.
29. Sontag TJ & Parker RS (2002) Cytochrome P450 omegahydroxylase pathway of tocopherol catabolism. Novel mechanism of regulation of vitamin E status. J Biol Chem 277, 25290-25296.
30. Floyd RA & Hensley K (2002) Oxidative stress in brain aging. Implications for therapeutics of neurodegenerative diseases. Neurobiol Aging 23, 795-807.
31. Morrow JD, Hill KE, Burk RF, et al. (1990) A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci U S A 87, 9383-9387.
32. Montine KS, Quinn JF, Zhang J, et al. (2004) Isoprostanes and related products of lipid peroxidation in neurodegenerative diseases. Chem Phys Lipids 128, 117-124.
33. Cuddihy SL, Ali SS, Musiek ES, et al. (2008) Prolonged alphatocopherol deficiency decreases oxidative stress and unmasks alpha -tocopherol-dependent regulation of mitochondrial function in brain. J Biol Chem 283, 6915-6924.
34. Kolosova NG, Shcheglova TV, Sergeeva SV, et al. (2006) Long-term antioxidant supplementation attenuates oxidative stress markers and cognitive deficits in senescent-accelerated OXYS rats. Neurobiol Aging 27, 1289-1297.
35. De AK & Darad R (1988) Physiological antioxidants and antioxidative enzymes in vitamin E-deficient rats. Toxicol Lett 44, 47-54.
36. Devi SA & Kiran TR (2004) Regional responses in antioxidant system to exercise training and dietary vitamin E in aging rat brain. Neurobiol Aging 25, 501-508.
37. Tong Y, Zhou W, Fung V, et al. (2005) Oxidative stress potentiates BACE1 gene expression and Abeta generation. J Neural Transm 112, 455-469.
38. Melo JB, Agostinho P & Oliveira CR (2003) Involvement of oxidative stress in the enhancement of acetylcholinesterase activity induced by amyloid beta-peptide. Neurosci Res 45, 117-127.
39. Caccamo A, Oddo S, SugarmanMC, et al. (2005) Age- and regiondependent alterations in Abeta-degrading enzymes: implications for Abeta-induced disorders. Neurobiol Aging 26, 645-654.
40. Fukami S, Watanabe K, Iwata N, et al. (2002) Abeta-degrading endopeptidase, neprilysin, in mouse brain: synaptic and axonal localization inversely correlating with Abeta pathology. Neurosci Res 43, 39-56.
41. Calabrese V, Scapagnini G, Colombrita C, et al. (2003) Redox regulation of heat shock protein expression in aging and neurodegenerative disorders associated with oxidative stress: a nutritional approach. Amino Acids 25, 437-444.
42. Schipper HM, Cisse S & Stopa EG (1995) Expression of heme oxygenase-1 in the senescent and Alzheimer-diseased brain. Ann Neurol 37, 758-768.
43. Hosomi A, Goto K, Kondo H, et al. (1998) Localization of alpha-tocopherol transfer protein in rat brain. Neurosci Lett 256, 159-162.
44. Copp RP, Wisniewski T, Hentati F, et al. (1999) Localization of alpha-tocopherol transfer protein in the brains of patients with ataxia with vitamin E deficiency and other oxidative stress related neurodegenerative disorders. Brain Res 822, 80-87.
45. Leonard SW, Terasawa Y, Farese RV Jr, et al. (2002) Incorporation of deuterated RRR- or all-rac-alpha-tocopherol in plasma and tissues of alpha-tocopherol transfer protein-null mice. Am J Clin Nutr 75, 555-560.
46. Hyland S, Muller D, Hayton S, et al. (2006) Cortical gene expression in the vitamin E-deficient rat: possible mechanisms for the electrophysiological abnormalities of visual and neural function. Ann Nutr Metab 50, 433-441.
47. Rota C, Rimbach G, Minihane AM, et al. (2005) Dietary vitamin E modulates differential gene expression in the rat hippocampus: potential implications for its neuroprotective properties. Nutr Neurosci 8, 21-29.
48. Gohil K, Schock BC, Chakraborty AA, et al. (2003) Gene expression profile of oxidant stress and neurodegeneration in transgenic mice deficient in alpha-tocopherol transfer protein. Free Radic Biol Med 35, 1343-1354.
49. Frank J, Lundh T, Parker RS, et al. (2003) Dietary (+)-catechin and BHT markedly increase alpha-tocopherol concentrations in rats by a tocopherol-omega-hydroxylase-independent mechanism. J Nutr 133, 3195-3199.
50. Frank J, Lundh T, Parker RS, et al. (2003) Dietary (+)-catechin and BHT markedly increase a-tocopherol concentrations in rats by a tocopherol-v- hydroxylase-independent mechanism. J Nutr 133, 3195-3199.
51. Kamal-Eldin A, Frank J, Razdan A, et al. (2000) Effects of dietary phenolic compounds on tocopherol, cholesterol, and fatty acids in rats. Lipids 35, 427-435.
52. Daniel JW & Gage JC (1965) The absorption and excretion of butylated hydroxytoluene (BHT) in the rat. Food Cosmet Toxicol 3, 405-415.
53. Thompson JA, Bolton JL & Malkinson AM (1991) Relationship between the metabolism of butylated hydroxytoluene (BHT) and lung tumor promotion in mice. Exp Lung Res 17, 439-453.
54. Conacher HB, Iverson F, Lau PY, et al. (1986) Levels of BHA and BHT in human and animal adipose tissue: interspecies extrapolation. Food Chem Toxicol 24, 1159-1162.
55. Gaedicke S, Zhang X, Schmelzer C, et al. (2008) Vitamin E dependent microRNA regulation in rat liver. FEBS Lett 582, 3542-3546.
56. Honig LS & Rosenberg RN (2000) Apoptosis and neurologic disease. Am J Med 108, 317-330.
57. Lu J, Moochhala S, Kaur C, et al. (2000) Changes in apoptosisrelated protein (p53, Bax, Bcl-2 and Fos) expression with DNA fragmentation in the central nervous system in rats after closed head injury. Neurosci Lett 290, 89-92.